ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Tianhao Li
Matched on ORCID iD 0000-0001-9500-6584; OpenAlex author ID A5101432512. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2020: 1 paper · 2021: none · 2022: 4 papers · 2023: 1 paper
Papers 6
- Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses. Co-author DOI 10.1016/j.heliyon.2023.e20464↗
- Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2022.e10416↗
- CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. First author DOI 10.1186/s12935-022-02768-8↗
- Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs. Co-author DOI 10.1186/s12935-022-02785-7↗
- Multidrug resistance genes screening of pancreatic cancer based on sensitivity profile to chemotherapeutic drugs Co-author DOI 10.21203/rs.3.rs-1759071/v2↗
- Pancreatic Cancer With Ovarian Metastasis: Clinical Features, Diagnosis and Management Co-author DOI 10.21203/rs.3.rs-32859/v1↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Weibin Wang · 6 shared papers, 2020–2023 · strength 0.95
- Paper Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. DOI 10.1016/j.heliyon.2022.e10416↗
- Paper Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses. DOI 10.1016/j.heliyon.2023.e20464↗
- Paper CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. DOI 10.1186/s12935-022-02768-8↗
- Bangbo Zhao · 5 shared papers, 2022–2023 · strength 0.83
- Paper Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. DOI 10.1016/j.heliyon.2022.e10416↗
- Paper Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses. DOI 10.1016/j.heliyon.2023.e20464↗
- Paper CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. DOI 10.1186/s12935-022-02768-8↗
- Yuanyang Wang · 5 shared papers, 2022–2023 · strength 0.83
- Paper Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. DOI 10.1016/j.heliyon.2022.e10416↗
- Paper Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses. DOI 10.1016/j.heliyon.2023.e20464↗
- Paper CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. DOI 10.1186/s12935-022-02768-8↗
- Zeru Li · 5 shared papers, 2022–2023 · strength 0.83
- Paper Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. DOI 10.1016/j.heliyon.2022.e10416↗
- Paper Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses. DOI 10.1016/j.heliyon.2023.e20464↗
- Paper CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. DOI 10.1186/s12935-022-02768-8↗
- Xiaoying Yang · 4 shared papers, 2022–2023 · strength 0.64
- Paper Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses. DOI 10.1016/j.heliyon.2023.e20464↗
- Paper CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. DOI 10.1186/s12935-022-02768-8↗
- Paper Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeut… DOI 10.1186/s12935-022-02785-7↗
- Cheng‐Feng Qin · 3 shared papers, 2022 · strength 0.50
- Paper Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. DOI 10.1016/j.heliyon.2022.e10416↗
- Paper CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. DOI 10.1186/s12935-022-02768-8↗
- Paper Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeut… DOI 10.1186/s12935-022-02785-7↗
- Tianyu Li · 3 shared papers, 2022 · strength 0.47
- Paper CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. DOI 10.1186/s12935-022-02768-8↗
- Paper Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeut… DOI 10.1186/s12935-022-02785-7↗
- Paper Multidrug resistance genes screening of pancreatic cancer based on sensitivity profile to chemotherapeutic drugs DOI 10.21203/rs.3.rs-1759071/v2↗
- Xingtong Zhou · 2 shared papers, 2020–2023 · strength 0.29
- Cheng Qin · 1 shared paper, 2023 · strength 0.17
- Yutong Zhao · 1 shared paper, 2022 · strength 0.16
- Cheng Yong Qin · 1 shared paper, 2022 · strength 0.16
- Xudong Liu · 1 shared paper, 2020 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.